Other OTC Pharmaceuticals (Pharmacies) - Central Asia

  • Central Asia
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$93.83m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.68%, resulting in a market volume of US$102.00m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.18 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Central Asia is witnessing significant development and growth due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trend. Customer preferences play a crucial role in the development of the Other OTC Pharmaceuticals (Pharmacies) market in Central Asia. Consumers in this region are increasingly seeking convenience and accessibility when it comes to healthcare products. They prefer to have easy access to over-the-counter (OTC) medications and pharmaceuticals without the need for a prescription. This preference for self-medication and the ability to purchase OTC products directly from pharmacies has led to an increased demand for these products in Central Asia. Trends in the market also contribute to the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Central Asia. One notable trend is the rising awareness and adoption of preventive healthcare practices among the population. People are becoming more proactive in managing their health and are turning to OTC pharmaceuticals for preventive measures. This trend is driving the demand for a wide range of OTC products, including vitamins, dietary supplements, and personal care products. Another trend in the market is the increasing popularity of online pharmacies. With the advancement of technology and the widespread use of the internet, online pharmacies have emerged as a convenient and accessible option for consumers in Central Asia. Online platforms provide a wide range of OTC pharmaceuticals, allowing customers to browse and purchase products from the comfort of their homes. This trend is particularly appealing to busy urban dwellers who may not have the time to visit physical pharmacies. Local special circumstances also contribute to the development of the Other OTC Pharmaceuticals (Pharmacies) market in Central Asia. The region has a growing middle class with increasing disposable income, which enables them to afford healthcare products and services. Additionally, Central Asia is experiencing urbanization and population growth, leading to a higher demand for healthcare products and services. Underlying macroeconomic factors further support the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Central Asia. The region is witnessing economic growth and stability, which boosts consumer confidence and purchasing power. Furthermore, governments in Central Asia are investing in healthcare infrastructure and promoting the development of the pharmaceutical sector, creating a favorable business environment for pharmacies. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Central Asia is developing and growing due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The increasing demand for convenience and accessibility, rising awareness of preventive healthcare, the popularity of online pharmacies, and the region's economic growth all contribute to this positive trend.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)